Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | DPP4 | P27487 | 1/20 | 0.39 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.39 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.39 |
| ▸ | GRM8 | O00222 | 1/20 | 0.34 |
| ▸ | GRM6 | O15303 | 1/20 | 0.34 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.34 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.34 |
| ▸ | GSR | P00390 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.34 |
| ▸ | GRM5 | P41594 | 1/20 | 0.34 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.34 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.34 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.34 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.34 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL726834 | 1.00 | ALOX15 (0.52) | ALOX15BLMPMP22KMT2ADPP4 | |
| SCHEMBL711607 | 0.92 | ALOX15 (0.60) | ALOX15BLMPMP22KMT2ADPP4 | |
| SCHEMBL9452863 | 0.89 | ALOX15 (0.48) | ALOX15BLMPMP22KMT2ADPP4 | |
| SCHEMBL5187828 | 0.89 | ALOX15 (0.39) | ALOX15BLMPMP22KMT2ADPP4 | |
| SCHEMBL5033341 | 0.89 | ALOX15 (0.53) | ALOX15BLMPMP22KMT2ADPP4 | |
| SCHEMBL17559225 | 0.88 | ALOX15 (0.42) | ALOX15BLMPMP22KMT2ADPP4 | |
| SCHEMBL11061010 | 0.87 | ALOX15 (0.36) | ALOX15BLMPMP22KMT2ADPP9 | |
| SCHEMBL995487 | 0.87 | ALOX15 (0.36) | ALOX15BLMPMP22KMT2ADPP9 | |
| SCHEMBL14486156 | 0.84 | ALOX15 (0.33) | ALOX15BLMPMP22KMT2A | |
| SCHEMBL3178198 | 0.84 | ALOX15 (0.52) | ALOX15BLMPMP22KMT2ADPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 619 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060040857-A1 | 1-Desamino-8-a-arginyl vasopressin analogs | UNQ TECHNOLOGY TRANSFER LLC. (US) | 2006-02-23 | — | — | US | claimed |
| US-6075141-A | N-ALPHA-PROTECTED AMINO ACID ESTER DERIVATIVES ARE USEFUL FOR MAKING PEPTIDES AND POLYPEPTIDES | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2000-06-13 | — | — | US | claimed |
| CN-117903324-B | Pharmaceutical preparation for targeted degradation of hepatitis B virus X protein and application thereof | 珠海市人民医院 | 2024-07-23 | — | — | CN | disclosed |
| CN-117659116-B | Preparation method of tyrosine oligopeptide | 珠海瑞德林生物有限公司 | 2024-05-10 | — | — | CN | disclosed |
| CN-117903324-A | Pharmaceutical preparation for targeted degradation of hepatitis B virus X protein and application thereof | 珠海市人民医院 | 2024-04-19 | — | — | CN | disclosed |
| WO-2024074847-A1 | COMPOSITIONS FOR DETECTING BIOLOGICAL AGENTS | PATH SPRAY LTD (GB) | 2024-04-11 | — | — | WO | disclosed |
| WO-2024069175-A1 | CLOSTRIDIAL NEUROTOXINS COMPRISING AN ACTIVATING ENDOSOMAL PROTEASE CLEAVAGE SITE | IPSEN BIOPHARM LIMITED (GB) | 2024-04-04 | — | — | WO | disclosed |
| WO-2024069176-A1 | CLOSTRIDIAL NEUROTOXINS COMPRISING AN ACTIVATING EXOGENOUS PROTEASE CLEAVAGE SITE | IPSEN BIOPHARM LIMITED (GB) | 2024-04-04 | — | — | WO | disclosed |
| WO-2024069191-A1 | CLOSTRIDIAL NEUROTOXIN FOR USE IN A TREATMENT OF BLADDER PAIN SYNDROME | IPSEN BIOPHARM LIMITED (GB) | 2024-04-04 | — | — | WO | disclosed |
| WO-2024057031-A1 | CELL-FREE CLOSTRIDIAL NEUROTOXIN ASSAYS | IPSEN BIOPHARM LIMITED (GB) | 2024-03-21 | — | — | WO | disclosed |
| CN-117659116-A | Preparation method of tyrosine oligopeptide | 珠海瑞德林生物有限公司 | 2024-03-08 | — | — | CN | disclosed |
| WO-1996020955-A1 | PURIFIED THROMBOPOIETIN AND METHOD OF MAKING IT | ZYMOGENETICS, INC. (US) | 1996-07-11 | — | — | WO | disclosed |
| WO-1996017067-A1 | METHOD FOR SECRETING THROMBOPOIETIN POLYPEPTIDES | ZYMOGENETICS, INC. (US) | 1996-06-06 | — | — | WO | disclosed |
| WO-1995021920-A1 | HEMATOPOIETIC PROTEIN AND MATERIALS AND METHODS FOR MAKING IT | ZYMOGENETICS, INC. (US) | 1995-08-17 | — | — | WO | disclosed |
| US-5428128-A | Forming amino acid chain of polypeptide, conjugating non-antigenic polymer to blocking groups, introducing said polymer at each point of synthesis, continuing synthesis of amino acid chain | MENSI-FATTOHI NAHLA (US) | 1995-06-27 | — | — | US | disclosed |
| WO-1995000162-A1 | SITE SPECIFIC SYNTHESIS OF CONJUGATED PEPTIDES | ENZON, INC. (US) | 1995-01-05 | — | — | WO | disclosed |
| CN-1095481-A | Measure juvenile cell reagent | TOA MEDICAL ELECTRONICS (JP) | 1994-11-23 | — | — | CN | disclosed |
| US-5240602-A | Silica solid-support-polyethylene glycol binder-hydrophilic spacer activated coupler ligand | CHROMATOCHEM, INC. (US) | 1993-08-31 | — | — | US | disclosed |
| US-5141870-A | Transforming plants with mutant fragment confers herbicide resistance | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-08-25 | — | — | US | disclosed |
| EP-0105193-A2 | Spergualin-related compounds, processes for the preparation thereof and their use as medicaments | MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) | 1984-04-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060040857-A1 | 1-Desamino-8-a-arginyl vasopressin analogs | ARGLU1, AVPR2, AVPR1A | ALOX15 3303/4885BLM 3301/4885PMP22 4604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.